The identification and developmental requirements of colonic CD169 macrophages

Immunology
|June 3, 2014
PubMed

Insights

Researchers discovered a new type of CD169-positive macrophage in the colon. Their development is independent of lymphotoxin-alpha but relies on vitamin A, unlike those in spleen and lymph nodes.

Area of Science:

  • Immunology
  • Gastroenterology
  • Cell Biology

Background:

  • CD169-positive macrophages act as crucial gatekeepers in lymphoid organs, capturing pathogens.
  • Their presence and function in the colon, a site with high bacterial load, remain largely unexplored.

Purpose of the Study:

  • To identify and characterize CD169-positive macrophages in the murine colon.
  • To investigate the factors influencing the development of these colonic macrophages.

Main Methods:

  • Flow cytometry analysis of colonic lamina propria macrophages.
  • Assessment of CD169+ macrophage populations in genetically modified mice (MyD88-deficient, lymphotoxin-alpha-deficient, vitamin A-deficient) and germ-free conditions.

Main Results:

  • A distinct population of CD169+ macrophages (CD115+ F4/80lo CD11clo) was identified in the colonic lamina propria, primarily around crypts.
  • Colonic CD169+ macrophage presence was unaffected by MyD88-mediated Toll-like receptor signaling deficiency or bacterial eradication.
  • Unlike splenic CD169+ macrophages, colonic CD169+ macrophage development was independent of lymphotoxin-alpha.
  • Vitamin A deficiency led to reduced numbers of colonic CD169+ macrophages, while splenic populations remained unaffected.

Conclusions:

  • A novel subset of CD169-positive macrophages exists in the colonic lamina propria.
  • The differentiation of these colonic macrophages is distinct from their lymphoid counterparts, being independent of lymphotoxin-alpha signaling and dependent on vitamin A.